![](https://investorshub.advfn.com/uicon/492199.png?cb=1470954815)
Friday, January 18, 2019 11:23:11 AM
The address in last weeks filing was not Conor Flannery’s personal address but that of JLL. It’s possible(although I can’t say conclusively) that JLL is somewhat involved in Inspyr Therapeutics,perhaps even taking a controlling interest in the company.
Here is the address in the filing:
![](http://investorshub.advfn.com/uimage/uploads/2019/1/16/jnbirflannery14c2.png)
That is the address for JLL:
![](http://investorshub.advfn.com/uimage/uploads/2019/1/16/bqdlpflanneryjlladdress.png)
Recent RBSH News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/21/2023 09:19:43 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/14/2023 08:36:33 PM
Maybacks Global Entertainment and ZEASN Technology Private Ltd. Sign Global Licensing Agreement • AHRO • Aug 8, 2024 7:00 AM
SANUWAVE Will Host a Conference Call on August 13, 2024 at 8:30 AM (ET) to Present Q2 Financial Results • SNWV • Aug 8, 2024 6:59 AM
Kona Gold Beverage Inc. Signs Letter of Intent with Bemax, Inc. to Sell Kona Gold, LLC • BMXC • Aug 7, 2024 10:00 AM
Btab Ecommerce Group, Inc. Launches Investor Connect AI Chatbot for Enhanced Investor Engagement and Lead Generation • BBTT • Aug 7, 2024 9:00 AM
Hydromer, Inc. Announces Preliminary Unaudited Second Quarter 2024 Financial Results and Provides Business Update • HYDI • Aug 7, 2024 8:52 AM
North Bay Resources Announces Mt. Vernon Gold Mine Startup, Sierra County, California • NBRI • Aug 5, 2024 9:00 AM